BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








 Company News
Repros Therapeutics Inc. (RPRX) Fully Enrolls First Of Two Previously Announced Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 4/14/2014 9:14:57 AM    More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/18/2014 8:57:38 AM    More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/17/2014 9:10:37 AM    More...
Repros Therapeutics Inc. (RPRX) Reports Fourth Quarter And Year End 2013 Financial Results 3/13/2014 8:51:02 AM    More...
Repros Therapeutics Inc. (RPRX) Reports Findings From The Six Month Study Of Androxal® In Men With Secondary Hypogonadism 2/10/2014 9:24:02 AM    More...
Repros Therapeutics Inc. (RPRX) Meets With FDA To Discuss Data Requirements For Androxal® In The Treatment Of Secondary Hypogonadism 2/6/2014 9:41:43 AM    More...
Repros Therapeutics Inc. (RPRX) Initiates Two Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 1/8/2014 9:08:16 AM    More...
Repros Therapeutics Inc. (RPRX) Adds Marketing And Commercialization Expertise To Board Of Directors 12/20/2013 9:55:32 AM    More...
Repros Therapeutics Inc. (RPRX) To Present Data On The Benefits Of Testosterone Restoration With Androxal® Compared To T Replacement With Gels At 9th Men's Health World Congress 11/26/2013 9:57:58 AM    More...
FDA Schedules Face To Face Meeting With Repros Therapeutics Inc. (RPRX) To Discuss Androxal® Efficacy 11/25/2013 9:29:43 AM    More...
12345678910...

//-->